QUINAZOLINONE DERIVATIVES USEFUL AS VANILLOID ANTAGONISTS

The present specification relates to the use of a quinazolinone compound of the formula (I) wherein R1, R2, R3, R4, R5 and m are as defined in the specification and in the claims, in free form or in salt form, and, where possible, in acid addition salt form.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CULSHAW, A. J. NOVARTIS PHARMACEUTICALS UK LTD, DZIADULEWICZ, E.K. NOVARTIS PHARMACEUTICALS UK LTD, HART, TERANCE, BRAIN, C. T. NOVARTIS PHARMACEUTICALS UK LTD, RITCHIE, T. J. NOVARTIS PHARMACEUTICALS UK LTD
Format:	Patent
Sprache:	eng ; pol
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present specification relates to the use of a quinazolinone compound of the formula (I) wherein R1, R2, R3, R4, R5 and m are as defined in the specification and in the claims, in free form or in salt form, and, where possible, in acid addition salt form.